Dr-Thankamma-V-Ajithkumar
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Consultant Clinical Oncologist_Headshot_Dr-Thankamma-V-Ajithkumar.jpg

Dr Thankamma V Ajithkumar

Dr Thankamma V Ajithkumar
Thankamma
V Ajithkumar
MBBS DMRT MD FRCR FRCP MBA
Consultant Clinical Oncologist

Languages spoken

English, Malayalam

Expert in

Radiotherapy

Interested in

Optimize the combination of radiotherapy with novel agents in hepato-pancreatico-biliary tumours

Overview

Centres

Cambridge
Cambridge

Fordham Rd, Newmarket CB8 7XN

52.26243294702835, 0.3985662288360208
/uk/our-centres/cambridge

Dr TV Ajithkumar is a Consultant Clinical Oncologist at Addenbrooke’s Hospital. He qualified in medicine from Trivandrum Medical College, India. He undertook a research fellowship in the Royal Marsden Hospital, London followed by speciality training in Clinical Oncology in the Eastern Deanery before becoming a Consultant Clinical Oncologist Bristol Oncology Centre in 2006. He moved back to East Anglia in 2009 as a Consultant in Clinical Oncology at the Norfolk and Norwich University Hospitals and subsequently to Cambridge in 2014.

His research interest is to optimize the combination of radiotherapy with novel agents in hepato-pancreatico-biliary tumours to improve clinical outcomes. Dr Ajithkumar is the radiotherapy research lead for the Eastern Cancer Research Network.

He is the lead editor of three oncology text books :Specialist training in Oncology (Elsevier), Oxford Desk Reference in Oncology, and Oxford Case histories in Oncology and is the lead author of the upcoming text book, Oxford Specialist Handbook in Oncology-Radiotherapy planning.

Career positions

Current position(s)
  • Consultant Clinical Oncologist

Education

Universities
  • Trivandrum Medical College
Fellowship
  • Royal Marsden Hospital - London
Residencies
  • Addenbrooke’s Hospital

Expertise and interests

Expertise
  • Consultant Clinical Oncologist
  • Radiotherapy
Interests
  • Advanced techniques for haematological radiotherapy
  • Radiotherapy, including SABR for hepato-biliary and pancreatic cancers
  • Paediatric radiation Oncology

Professional association

  • Chair, SIOPE Brain tumour radiotherapy group
  • Radiotherapy lead for SIOPE Non-germinomatous germ cell tumours
  • Principal investigator of Re-irradiation working group; International consortium on Paediatric Normal Tissue Effects in the Clinic (PENTEC)
  • Member: Quality and Excellence in Radiotherapy and Imaging for Children and Adolescents with Cancer across Europe in Clinical Trials (QUARTET) project
  • Member: NCRI CCLG CNS group and NCRI pancreatic cancer working group
  • Radiotherapy lead for NCRI CCLG GCT subgroup and national advisory panel
  • Member, Clinical and Translational Radiotherapy Research Working Group (NCRI- CtRAd)
  • Editorial member of Royal College of Radiologist Journal Clinical Oncology

Accomplishments

Publications

  • Specialist training in Oncology (Elsevier)
  • Oxford Desk Reference in Oncology
  • Oxford Case histories in Oncology
  • Lead author of the upcoming text book, Oxford Specialist Handbook in Oncology-Radiotherapy planning
  • Novel techniques in radiotherapy and optimisation of the combination of drugs with stereotactic ablative radiotherapy.
  • Chief investigator of the PORTICO-SABR study, which evaluate the optimal combination of novel agents with SABR for operable pancreatic cancer